Daniela Carl, incoming CEO of the Guidelines International Network, is a senior leader with extensive experience in global research, education and membership institutions.

Passionate about supporting communities and driving positive change, she specializes in organizational growth, strategic planning, stakeholder engagement, and digital innovation. With a strong commitment to sustainability, equity, and inclusion, she has led transformational initiatives that have strengthened engagement, diversified income streams, and built global impact.

Daniela Carl, incoming CEO of the Guidelines International Network, is a senior leader with extensive experience in global research, education and membership institutions.

Passionate about supporting communities and driving positive change, she specializes in organizational growth, strategic planning, stakeholder engagement, and digital innovation. With a strong commitment to sustainability, equity, and inclusion, she has led transformational initiatives that have strengthened engagement, diversified income streams, and built global impact.

Roberta James is the Programme Lead at the Scottish Intercollegiate Guidelines Network (SIGN), which is part of Healthcare Improvement Scotland. She has responsibility for the currency, quality, validity and timely development and dissemination of SIGN guidelines. With 20 years of experience producing evidence-based guidelines at SIGN, she is interested in presenting recommendations in ways that fit the needs of professional and public audiences. Roberta is Vice-Chair of the Guideline International Network (GIN) Board of Trustees and a member of its Implementation working group. Roberta started her career as a research scientist after undergraduate and postgraduate study at Edinburgh University and before joining SIGN spent 10 years as a research scientist at the Medical Research Council Human Genetics Unit in Edinburgh, the Roslin Institute and the Cancer Research UK labs at the University of Edinburgh.

Roberta James is the Programme Lead at the Scottish Intercollegiate Guidelines Network (SIGN), which is part of Healthcare Improvement Scotland. She has responsibility for the currency, quality, validity and timely development and dissemination of SIGN guidelines. With 20 years of experience producing evidence-based guidelines at SIGN, she is interested in presenting recommendations in ways that fit the needs of professional and public audiences. Roberta is Vice-Chair of the Guideline International Network (GIN) Board of Trustees and a member of its Implementation working group. Roberta started her career as a research scientist after undergraduate and postgraduate study at Edinburgh University and before joining SIGN spent 10 years as a research scientist at the Medical Research Council Human Genetics Unit in Edinburgh, the Roslin Institute and the Cancer Research UK labs at the University of Edinburgh.

Robby Nieuwlaat is Associate Professor in the Department of Health Research Methods, Evidence, and Impact at McMaster University. He obtained MSc in health sciences (2001) and PhD in cardiovascular clinical epidemiology (2007) from Maastricht University in The Netherlands. He worked as a post-doctoral research fellow at the Population Health Research Institute in Hamilton from 2008 until becoming a faculty member at McMaster University in 2011. He is a researcher in the MacGRADE Centre of McMaster University, GRADE working group member, and has experience with developing practice guidelines as a methodology panel member and systematic review lead. He is also a researcher at the Michael G. DeGroote Cochrane Canada Centre at McMaster University, Cochrane Heart editorial board member, and has led several highly cited reviews. His research interests include advancing evidence synthesis methods for clinical decision-making, as well as optimizing implementation of recommended best practice. He is an author of over 100 peer-reviewed publications (h-index 41 in Google scholar).

Robby Nieuwlaat is Associate Professor in the Department of Health Research Methods, Evidence, and Impact at McMaster University. He obtained MSc in health sciences (2001) and PhD in cardiovascular clinical epidemiology (2007) from Maastricht University in The Netherlands. He worked as a post-doctoral research fellow at the Population Health Research Institute in Hamilton from 2008 until becoming a faculty member at McMaster University in 2011. He is a researcher in the MacGRADE Centre of McMaster University, GRADE working group member, and has experience with developing practice guidelines as a methodology panel member and systematic review lead. He is also a researcher at the Michael G. DeGroote Cochrane Canada Centre at McMaster University, Cochrane Heart editorial board member, and has led several highly cited reviews. His research interests include advancing evidence synthesis methods for clinical decision-making, as well as optimizing implementation of recommended best practice. He is an author of over 100 peer-reviewed publications (h-index 41 in Google scholar).

Elie Akl is a tenured Professor of Medicine at the American university of Beirut (AUB). He serves as the Associate Dean for Clinical Research at the Faculty of Medicine, leads the division of General Internal Medicine and Geriatrics (GIMG) at AUB Medical Center, directs the AUB GRADE Center, and co-directs the Center for systematic reviews of health policy and systems research (SPARK). His research expertise is in systematic reviews, practice guidelines, and conflicts of interest. He serves as a guideline methodologist for a number of leading professional organizations and the World Health Organization. He published close to 500 peer-reviewed papers and was listed by Thomson Reuters as one of the 2015 “world’s most influential scientific minds” and as one of the “Highly Cited Researchers” yearly since 2015.

Elie Akl is a tenured Professor of Medicine at the American university of Beirut (AUB). He serves as the Associate Dean for Clinical Research at the Faculty of Medicine, leads the division of General Internal Medicine and Geriatrics (GIMG) at AUB Medical Center, directs the AUB GRADE Center, and co-directs the Center for systematic reviews of health policy and systems research (SPARK). His research expertise is in systematic reviews, practice guidelines, and conflicts of interest. He serves as a guideline methodologist for a number of leading professional organizations and the World Health Organization. He published close to 500 peer-reviewed papers and was listed by Thomson Reuters as one of the 2015 “world’s most influential scientific minds” and as one of the “Highly Cited Researchers” yearly since 2015.

Pablo Alonso is Coordinator of the Clinical Epidemiology and Health Services group at the Institut de Recerca Sant Pau, and senior researcher at the Iberoamerican Cochrane Centre and at the CIBER in Epidemiology and Public Health (CIBERESP) network. Director of the Barcelona GRADE Centre, based at IR Sant Pau, and member of the GRADE Advisory Board (known as the GRADE Guidance Group). He is also a member of the Board of the International Guidelines Network and former Director of the Scientific Committee of the National Guidelines Programme from the Spanish Ministry of Health. He was born in Madrid, where he trained in family medicine; later obtained his PhD in Medicine at the Autonomous University of Barcelona and spent two years as a researcher at McMaster University in Canada and one year at the Knowledge Center, in Norway. Over the last decade, he has conducted methods research, both in systematic reviews and guidelines, including a broad range of aspects, with a special focus in incorporating the public perspective, and improving decision-making in healthcare, with the development of evidence to decision frameworks. As methodologist she contributed to numerous guidelines on a variety of topics, both locally and internationally. Pablo Alonso is the author of more than 350 peer-reviewed publications.

Pablo Alonso is Coordinator of the Clinical Epidemiology and Health Services group at the Institut de Recerca Sant Pau, and senior researcher at the Iberoamerican Cochrane Centre and at the CIBER in Epidemiology and Public Health (CIBERESP) network. Director of the Barcelona GRADE Centre, based at IR Sant Pau, and member of the GRADE Advisory Board (known as the GRADE Guidance Group). He is also a member of the Board of the International Guidelines Network and former Director of the Scientific Committee of the National Guidelines Programme from the Spanish Ministry of Health. He was born in Madrid, where he trained in family medicine; later obtained his PhD in Medicine at the Autonomous University of Barcelona and spent two years as a researcher at McMaster University in Canada and one year at the Knowledge Center, in Norway. Over the last decade, he has conducted methods research, both in systematic reviews and guidelines, including a broad range of aspects, with a special focus in incorporating the public perspective, and improving decision-making in healthcare, with the development of evidence to decision frameworks. As methodologist she contributed to numerous guidelines on a variety of topics, both locally and internationally. Pablo Alonso is the author of more than 350 peer-reviewed publications.

Sue Brennan is the Director of the Melbourne GRADE Centre and a Senior Research Fellow at Cochrane Australia, in the School of Public Health and Preventive Medicine, Monash University. Her field of expertise is systematic review and guideline methodology, with a focus on evidence-informed decision-making in public health where contributions include leading reviews for national guidelines on lower risk alcohol consumption and infection control. Through leadership roles in the international GRADE working group and Cochrane, she works with researchers, national policy-makers and guideline developers to implement best practice methods in evidence synthesis and guideline development. She has trained more than 1000 participants in GRADE and systematic review methodology, is an author of four core chapters in the Cochrane Handbook, and co-author of the PRISMA, PRIOR and SWIM reporting guidelines.

Sue Brennan is the Director of the Melbourne GRADE Centre and a Senior Research Fellow at Cochrane Australia, in the School of Public Health and Preventive Medicine, Monash University. Her field of expertise is systematic review and guideline methodology, with a focus on evidence-informed decision-making in public health where contributions include leading reviews for national guidelines on lower risk alcohol consumption and infection control. Through leadership roles in the international GRADE working group and Cochrane, she works with researchers, national policy-makers and guideline developers to implement best practice methods in evidence synthesis and guideline development. She has trained more than 1000 participants in GRADE and systematic review methodology, is an author of four core chapters in the Cochrane Handbook, and co-author of the PRISMA, PRIOR and SWIM reporting guidelines.

Paul is the Director for the Centre for Guidelines at NICE and member of NICE’s executive team and board. He has been with NICE since 2009, where he was responsible for setting up the Institute’s accreditation programme for guideline developers. This programme evaluated the quality of processes used by organisations that developed guidelines, and awarded an accreditation mark to those achieving the required standard. The aim was to raise the quality of guideline production. Before joining NICE, Paul spent over 20 years in international medical publishing and communications, focusing on evidence to aid healthcare decision making and therapeutics. Now based in Manchester in the UK, during his career Paul has lived, worked and travelled internationally as part of his role. Paul is a member of the Royal Pharmaceutical Society and has a postgraduate diploma in publishing studies.

Paul is the Director for the Centre for Guidelines at NICE and member of NICE’s executive team and board. He has been with NICE since 2009, where he was responsible for setting up the Institute’s accreditation programme for guideline developers. This programme evaluated the quality of processes used by organisations that developed guidelines, and awarded an accreditation mark to those achieving the required standard. The aim was to raise the quality of guideline production. Before joining NICE, Paul spent over 20 years in international medical publishing and communications, focusing on evidence to aid healthcare decision making and therapeutics. Now based in Manchester in the UK, during his career Paul has lived, worked and travelled internationally as part of his role. Paul is a member of the Royal Pharmaceutical Society and has a postgraduate diploma in publishing studies.

Miranda is an epidemiologist with a background in health sciences and a keen interest in evidence-based health care. After her PhD in infectious diseases epidemiology she worked as senior researcher at the Dutch National Health Care Institute and senior staff member of Cochrane Netherlands. Currently she is an assistant professor and principal investigator at the department of Epidemiology and Data Science of the Amsterdam Medical Centers (University of Amsterdam). The focus of her research and teaching is evidence synthesis methodology, in particular guideline development and implementation. Her research line covers a broad spectrum of projects: from developing core outcome sets and risk of bias instruments to evaluation of guideline implementation and development of methodological frameworks. As methodologist she contributed to numerous guidelines on a variety of topics, for example for WHO and the European Commission. She is a board member of the GRADE working group, co-chair of the Dutch GRADE network and an active member of Cochrane.

Miranda is an epidemiologist with a background in health sciences and a keen interest in evidence-based health care. After her PhD in infectious diseases epidemiology she worked as senior researcher at the Dutch National Health Care Institute and senior staff member of Cochrane Netherlands. Currently she is an assistant professor and principal investigator at the department of Epidemiology and Data Science of the Amsterdam Medical Centers (University of Amsterdam). The focus of her research and teaching is evidence synthesis methodology, in particular guideline development and implementation. Her research line covers a broad spectrum of projects: from developing core outcome sets and risk of bias instruments to evaluation of guideline implementation and development of methodological frameworks. As methodologist she contributed to numerous guidelines on a variety of topics, for example for WHO and the European Commission. She is a board member of the GRADE working group, co-chair of the Dutch GRADE network and an active member of Cochrane.

Professor Joerg Meerpohl is director of the Institute for Evidence in Medicine at the Medical Center & Faculty of Medicine, University of Freiburg, Germany and founding director of the Freiburg GRADE Center, which was established in 2013. He is a board-qualified pediatrician and pediatric hematologist and oncologist by training. For more than a decade Prof. Meerpohl has been an active member of the GRADE working group and has worked as GRADE methodology advisor with national and international expert panels including WHO and the Robert Koch Institute in Germany. Professor Meerpohl is also the Director of Cochrane Germany. From 2015 to 2018, he has been an elected member of the Cochrane Governing Board. His main research interests include systematic review methodology, transparency in research, and guideline methodology. Professor Meerpohl has published more than 300 PubMed listed articles.

Professor Joerg Meerpohl is director of the Institute for Evidence in Medicine at the Medical Center & Faculty of Medicine, University of Freiburg, Germany and founding director of the Freiburg GRADE Center, which was established in 2013. He is a board-qualified pediatrician and pediatric hematologist and oncologist by training. For more than a decade Prof. Meerpohl has been an active member of the GRADE working group and has worked as GRADE methodology advisor with national and international expert panels including WHO and the Robert Koch Institute in Germany. Professor Meerpohl is also the Director of Cochrane Germany. From 2015 to 2018, he has been an elected member of the Cochrane Governing Board. His main research interests include systematic review methodology, transparency in research, and guideline methodology. Professor Meerpohl has published more than 300 PubMed listed articles.

Professor Zachary Munn is an advocate for evidence-based healthcare and for ensuring policy and practice is based on the best available evidence. Professor Munn is the founding Director of Health Evidence Synthesis, Recommendations and Impact (HESRI) in the School of Public Health at the University of Adelaide; Head of the Evidence Synthesis Taxonomy Initiative (ESTI); Founding Director of the JBI Adelaide GRADE Centre; past-Chair of the Guidelines International Network (GIN) and a National Health and Medical Research Council (NHMRC) Investigator. He is a systematic review, evidence implementation and guideline development methodologist. He has been involved in the conduct of dozens of systematic reviews, clinical and public health guidelines, evidence implementation and health services research projects.

Professor Zachary Munn is an advocate for evidence-based healthcare and for ensuring policy and practice is based on the best available evidence. Professor Munn is the founding Director of Health Evidence Synthesis, Recommendations and Impact (HESRI) in the School of Public Health at the University of Adelaide; Head of the Evidence Synthesis Taxonomy Initiative (ESTI); Founding Director of the JBI Adelaide GRADE Centre; past-Chair of the Guidelines International Network (GIN) and a National Health and Medical Research Council (NHMRC) Investigator. He is a systematic review, evidence implementation and guideline development methodologist. He has been involved in the conduct of dozens of systematic reviews, clinical and public health guidelines, evidence implementation and health services research projects.

Dr. Vivian Welch is editor in chief and acting CEO of the Campbell Collaboration, Director of the Methods Centre at the Bruyère Research Institute, and Associate Professor at University of Ottawa School of Epidemiology and Public Health. Her research interests include methods and reporting guidelines for synthesizing evidence on health equity.  She is also an avid cross-country skier, runner and mother of four.

Dr. Vivian Welch is editor in chief and acting CEO of the Campbell Collaboration, Director of the Methods Centre at the Bruyère Research Institute, and Associate Professor at University of Ottawa School of Epidemiology and Public Health. Her research interests include methods and reporting guidelines for synthesizing evidence on health equity.  She is also an avid cross-country skier, runner and mother of four.

Jun is a healthcare researcher with over 17 years of experience in evidence-based medicine. She is the Director of Nottingham Ningbo GRADE Centre at the University of Nottingham Ningbo (China), and lead for systematic review and clinical practice guidelines at the University of Nottingham (UK). The scope of her expertise spans across primary research and secondary synthesis. Her strength lies particularly in establishing national and international platform, promotes research collaboration and knowledge exchange. Born and raised in north China, educated in the UK, she has a keen interest in improving standards of care in LMIC and resource-limited settings. She is the founding member of China Clinical Practice Guideline Alliance (GUIDANCE) – the first and largest national platform for evidence-based guideline production in China. Jun has been an active reviewer/editor for Cochrane Collaboration since 2005, working across culture, continents, and stakeholders to promote evidence-based practice, particularly in guideline development and implementation. Besides those research activities, she enjoys teaching and knowledge sharing with other users in science community. Her teaching video has over 200,000 viewings on Youtube.

Jun is a healthcare researcher with over 17 years of experience in evidence-based medicine. She is the Director of Nottingham Ningbo GRADE Centre at the University of Nottingham Ningbo (China), and lead for systematic review and clinical practice guidelines at the University of Nottingham (UK). The scope of her expertise spans across primary research and secondary synthesis. Her strength lies particularly in establishing national and international platform, promotes research collaboration and knowledge exchange. Born and raised in north China, educated in the UK, she has a keen interest in improving standards of care in LMIC and resource-limited settings. She is the founding member of China Clinical Practice Guideline Alliance (GUIDANCE) – the first and largest national platform for evidence-based guideline production in China. Jun has been an active reviewer/editor for Cochrane Collaboration since 2005, working across culture, continents, and stakeholders to promote evidence-based practice, particularly in guideline development and implementation. Besides those research activities, she enjoys teaching and knowledge sharing with other users in science community. Her teaching video has over 200,000 viewings on Youtube.